AI, Dogma, and Drug Development

,
This limited rate of drug development success suggests that significant challenges may exist at the system level, warranting the acquisition, testing, and incorporation of innovative approaches and technologies to address this disparity.

This is a companion discussion topic for the original entry at https://www.insideprecisionmedicine.com/news-and-features/ai-dogma-and-drug-development/